SCHEMBL3958666

SCHEMBL3958666

COc1cccc2cc(-c3ccnc(NCCCN4CCN(C)CC4)n3)sc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 3/20 0.47
ADRA1A P35348 2/20 0.45
ADRA1D P25100 1/20 0.45
ADRA1B P35368 1/20 0.45
DRD2 P14416 4/20 0.43
HRH4 Q9H3N8 2/20 0.43
DRD3 P35462 1/20 0.43
FGFR1 P11362 3/20 0.43
TLR9 Q9NR96 1/20 0.43
TLR7 Q9NYK1 1/20 0.43
HTR1A P08908 4/20 0.42
HTR2A P28223 3/20 0.42
HTR7 P34969 3/20 0.42
HTR6 P50406 3/20 0.42
PGK1 P00558 1/20 0.41
AIMP2 Q13155 1/20 0.41
RAF1 P04049 1/20 0.41
BRAF P15056 1/20 0.41
EGFR P00533 1/20 0.41
SRC P12931 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3971664 0.90 SRC (0.47) MKNK1HRH4FGFR1HTR2AHTR7
SCHEMBL3961990 0.89 FGFR1 (0.49) MKNK1FGFR1EGFRSRCFGFR2
SCHEMBL3970234 0.86 MKNK1 (0.43) MKNK1HRH4FGFR1PGK1EGFR
SCHEMBL3969427 0.84 IKBKB (0.53) MKNK1HRH4FGFR1HTR2AHTR7
Hydrochloric Acid SCHEMBL3961561 0.83 IKBKB (0.52) MKNK1HRH4FGFR1HTR2AHTR7
SCHEMBL3964652 0.83 FGFR1 (0.45) DRD2FGFR1TLR9TLR7HTR1A
SCHEMBL3964419 0.83 FGFR1 (0.50) FGFR1PGK1EGFRSRCFGFR2
Hydrochloric Acid SCHEMBL3964159 0.82 FGFR1 (0.44) DRD2FGFR1TLR9TLR7HTR1A
SCHEMBL3963258 0.79 MKNK1 (0.46) MKNK1ADRA1AADRA1DADRA1BHRH4
SCHEMBL4075976 0.77 MKNK1 (0.45) MKNK1ADRA1AADRA1DADRA1BHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1989200-B1 [4-(BENZO[B]THIOPHEN-2-YL)-PYRIMIDIN-2-YL]-AMINE DERIVATIVES AS IKK-BETA INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES LILLY CO ELI (US) 2009-07-29 EP disclosed